Literature DB >> 8867630

Microbial oxidation of ebastine.

H Schwartz1, A Liebig-Weber, H Hochstätter, H Böttcher.   

Abstract

The microbial oxidation of ebastine to carebastine was investigated. Among the 15 micro-organisms examined, only the Cunninghamella strains showed the desired biotransformation. Cunninghamella blakesleeana oxidised the substrate within 7 days, via the intermediates alcohol and aldehyde, mainly to carebastine, the corresponding carboxylic acid. Optimisation of the culture conditions increased the yield from initially 10% up to a reproducible 40%. For the synthesis of carebastine a substrate concentration of 200 mg/l, a starting pH of 5.0 and the addition of 1% poly(vinyl alcohol) is favourable. The results achieved in experiments with shaking flasks are transferable to the fermentation scale and yielded 270 mg carebastine in a 3-1 fermentation of 600 mg ebastine. The progress of the reaction was detected by TLC and HPLC, the products were identified by mass spectrometry and NMR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8867630     DOI: 10.1007/bf00178610

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  15 in total

1.  Microbial models of mammalian metabolism.

Authors:  R V Smith; J P Rosazza
Journal:  J Pharm Sci       Date:  1975-11       Impact factor: 3.534

2.  Induction of cytochrome P-450 in Streptomyces griseus by soybean flour.

Authors:  F S Sariaslani; D A Kunz
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

3.  Stereoselective fungal metabolism of methylated anthracenes.

Authors:  C E Cerniglia; W L Campbell; P P Fu; J P Freeman; F E Evans
Journal:  Appl Environ Microbiol       Date:  1990-03       Impact factor: 4.792

Review 4.  Microbial enzymes for oxidation of organic molecules.

Authors:  F S Sariaslani
Journal:  Crit Rev Biotechnol       Date:  1989       Impact factor: 8.429

5.  Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.

Authors:  T Yamaguchi; T Hashizume; M Matsuda; M Sakashita; T Fujii; Y Sekine; M Nakashima; T Uematsu
Journal:  Arzneimittelforschung       Date:  1994-01

6.  Fungal metabolism of tert-butylphenyl diphenyl phosphate.

Authors:  M A Heitkamp; J P Freeman; D C McMillan; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1985-08       Impact factor: 4.792

7.  Sedation and antihistaminics.

Authors:  M Weiner
Journal:  Arzneimittelforschung       Date:  1982

8.  Transformation of 1- and 2-methylnaphthalene by Cunninghamella elegans.

Authors:  C E Cerniglia; K J Lambert; D W Miller; J P Freeman
Journal:  Appl Environ Microbiol       Date:  1984-01       Impact factor: 4.792

9.  Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.

Authors:  T Fujii; S Matsumoto; H Amejima; T Hatoyama; M Nakao; A Kagemoto; K Tanaka; H Miyazaki
Journal:  Arzneimittelforschung       Date:  1994-04

10.  Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.

Authors:  M Matsuda; M Sakashita; Y Mizuki; T Yamaguchi; T Fujii; Y Sekine
Journal:  Arzneimittelforschung       Date:  1994-01
View more
  1 in total

1.  Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; My Ann Nguyen; Jane Cameron; Shanlin Fu
Journal:  AAPS J       Date:  2017-04-28       Impact factor: 4.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.